ALS genetic modifiers that increase survival of SOD1 mice and are suitable for therapeutic development

Giulietta Riboldi1, Monica Nizzardo, Chiara Simone

  • 1Department of Neurological Sciences, Dino Ferrari Centre, University of Milan, IRCCS Fondazione Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.

Insights

Researchers reviewed 10 key genes in animal models of Amyotrophic Lateral Sclerosis (ALS). Modifying these genes may extend lifespan and slow disease progression in this motor neuron disease.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Amyotrophic Lateral Sclerosis (ALS) is a fatal motor neuron disease with no current cure.
  • Identifying molecular therapeutic targets is crucial for developing effective treatments for ALS.
  • Transgenic animal models are instrumental in studying ALS pathogenesis and evaluating potential therapeutic genes.

Purpose of the Study:

  • To review recent discoveries and research on potential molecular therapeutic targets for ALS.
  • To identify and analyze the 10 most promising genes that, when modulated, could impact ALS progression and lifespan in animal models.
  • To explore the interconnectedness of these genes and their involvement in common pathogenic pathways.

Main Methods:

  • Systematic review of studies involving transgenic ALS murine models crossed with animals expressing specific ALS target genes.
  • Selection of 10 key genes based on their demonstrated impact (up-regulation or down-regulation) on lifespan and disease mitigation in ALS animal models.
  • Analysis of identified genes for involvement in common biological pathways, including inflammation, cytoskeletal activity, and endoplasmic reticulum function.

Main Results:

  • Ten genes (XBP-1, NogoA/B, dynein, heavy/medium neurofilament, NOX1/2, MLC-mIGF-1, NSE-VEGF, MMP-9) were identified as promising targets.
  • Common pathways implicated in ALS pathogenesis include inflammation and cytoskeletal dynamics.
  • The endoplasmic reticulum plays a significant role in various selected gene pathways relevant to ALS.

Conclusions:

  • Modulating the identified genes holds potential for increasing lifespan and mitigating disease progression in ALS.
  • Inflammation, cytoskeletal activities, and endoplasmic reticulum function are critical interconnected pathways in ALS pathogenesis.
  • The findings suggest a potential underlying common pathway that links these identified genes and possibly others yet to be discovered in ALS.